PolarCool AB Stock NORDIC GROWTH MARKET

POLAR

SE0012570422

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 2024-12-05			5-day change	1st Jan Change
8.981 ^SEK	-4.66%		-4.66%	-88.62%

08-27	Polarcool reports higher revenue and a wider operating loss	FW
08-27	PolarCool AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Analysts' recommendations : PolarCool AB

25-03-17	Mangold reiterates buy and lowers the target price for Polarcool - mission analysis	FW
25-01-21	Mangold initiates coverage of Polarcool - sees upside of 90 percent	FW

More recommendations

Managers and Directors : PolarCool AB

Manager	Title	Age	Since
Erik Andersson CEO	Chief Executive Officer	44	-
Kim Isaksson CTO	Chief Tech/Sci/R&D Officer	-	2024-04-30
Simon Josefsson AUD	Comptroller/Controller/Auditor	30	-

Director	Title	Age	Since
Mats Vilhelm Forsman CHM	Chairman	79	2017-12-31
Gustaf Frithz CHM	Chairman	-	2022-01-05
Jonas Hagberg CHM	Chairman	45	-

More insiders

Polarcool AB is a Sweden-based medical device company that offers a controlled cooling treatment. The Company provides solutions on concussive and sub-concussive brain injuries such as PolarCap System. The device PolarCap System is intended as an acute treatment for concussion, as soon as possible after injury. PolarCap aims to reduce the metabolic demand in the brain, when a concussion occurs during sports. By lowering brain temperature rapidly through controlled cooling. With this System, the Company protects the athletes, their clubs as well as the financial losses occurring while an athlete recovers or having to quit the sport altogether. PolarCool AB is based in Lund, Sweden and the shares are listed on Spotlight Stock Market.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	15.8M 1.64M 1.41M 1.33M 1.21M 2.26M 156M 2.28M 6.08M 79.3M 6.14M 6.01M 252M	P/E 2024	-1.25x	P/E 2025	-1.46x
Enterprise Value	14.4M 1.49M 1.28M 1.21M 1.1M 2.06M 142M 2.08M 5.54M 72.25M 5.6M 5.47M 229M	EV / Sales 2024	12.7x	EV / Sales 2025	9.92x
Free-Float	99%	Yield 2024 *	-	Yield 2025	-

08-27	Polarcool reports higher revenue and a wider operating loss	FW
08-27	PolarCool AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-17	Polarcool calls extraordinary meeting to vote on delisting	FW
07-15	Polarcool takes out a bridge loan of 4 million Swedish kronor	FW
07-06	Polarcool wants to leave Spotlight ahead of possible US listing	FW
06-11	PolarCap to be utilized by multiple national teams during the FIFA World Cup	FW
06-11	PolarCool AB (publ.) Provides PolarCap to Several National Teams for Use During the FIFA World Cup	CI
05-28	PolarCool AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-28	Polarcool posts revenue growth as operating loss holds steady	FW
03-26	Achilles Capital Boosts Shareholding in PolarCool	MT
03-26	Achilles Capital increases its stake in Polarcool	FW
03-19	PolarCool signs agreement with top-tier Champions League club	FW
03-06	PolarCool secures MDSAP approval – proceeds with product application in Canada	FW

06-11	PolarCap® to be used by several national teams during the FIFA World Cup	AQ
03-26	Achilles Capital AB (publ.) increases its ownership in PolarCool through the acquisition of 100,000 shares	AQ
03-06	PolarCool Completes MDSAP Process Enabling Application for Product Approval in Canada	AQ
02-17	PolarCool Signs Agreement in Finland with Ice Hockey Club Ilves	AQ
02-12	PolarCool Signs Its Third Agreement in the British Elite Ice Hockey League with Manchester Storm	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
POLARCOOL AB	-4.66%	-4.66%	-	-	1.64M
A-TOP HEALTH BIOTECH CO., LTD.	-4.38%	+41.83%	-	-	1.35B
MIMEDX GROUP, INC.	-1.71%	+3.84%	-33.24%	-42.07%	670M
ROKIT HEALTHCARE INC.	+1.45%	+10.67%	+68.07%	-	361M
NIBEC CO., LTD.	-2.29%	-3.77%	-43.46%	-38.43%	123M
BONUS BIOGROUP LTD.	-2.26%	-3.89%	-32.68%	+12.34%	66.4M
Average	-2.31%	+2.43%	-10.33%	-22.72%	513.6M
Weighted average by Cap.	-2.71%	+5.35%	-4.26%	-37.34%

	2024	2025
Net sales	2.08M 216K 185K 175K 159K 298K 20.61M 301K 802K 10.45M 809K 792K 33.2M	2.4M 248K 213K 201K 183K 343K 23.71M 346K 922K 12.03M 931K 911K 38.2M
Net income	-11.02M -1.14M -981K -926K -843K -1.58M -109M -1.59M -4.24M -55.32M -4.28M -4.19M -176M	-16.73M -1.73M -1.49M -1.4M -1.28M -2.39M -165M -2.41M -6.44M -83.94M -6.5M -6.36M -267M
Net Debt	-7.38M -764K -657K -620K -565K -1.06M -73.01M -1.06M -2.84M -37.03M -2.87M -2.81M -118M	-1.4M -145K -125K -118K -107K -201K -13.9M -203K -541K -7.05M -546K -534K -22.39M

PolarCool AB Stock NORDIC GROWTH MARKET

Stocks

POLAR

SE0012570422

Biotechnology & Medical Research

Valuation : PolarCool AB

Latest news : PolarCool AB

Analysts' recommendations : PolarCool AB

Press Releases : PolarCool AB

Quotes and Performance

Managers and Directors : PolarCool AB

Bio Medical Devices

Financials

Company Profile